- Report
- December 2023
- 148 Pages
Global
From €3140EUR$3,560USD£2,718GBP
€3925EUR$4,450USD£3,397GBP
- Report
- May 2024
- 140 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- September 2023
- 160 Pages
Global
From €3174EUR$3,599USD£2,748GBP
- Report
- August 2024
- 150 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- August 2024
- 200 Pages
Global
From €3412EUR$3,869USD£2,954GBP
- Report
- August 2024
- 200 Pages
Global
From €3412EUR$3,869USD£2,954GBP
- Report
- August 2024
- 150 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- August 2024
- 150 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- April 2023
- 147 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- April 2023
- 147 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- February 2024
- 179 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Report
- July 2023
- 119 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Drug Pipelines
- February 2023
- 35 Pages
Global
From €17630EUR$19,990USD£15,262GBP
- Report
- April 2023
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- September 2023
- 115 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- August 2024
- 200 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3412EUR$3,869USD£2,954GBP
- Report
- June 2023
- 140 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 250 Pages
India
From €2460EUR$2,789USD£2,129GBP
- Report
- April 2023
- 160 Pages
Global
From €4365EUR$4,949USD£3,778GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more